Detalles de la búsqueda
1.
Publisher Correction: Tumor-necrosis factor impairs CD4+ T cell-mediated immunological control in chronic viral infection.
Nat Immunol
; 21(9): 1135, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32620862
2.
Tumor-necrosis factor impairs CD4(+) T cell-mediated immunological control in chronic viral infection.
Nat Immunol
; 17(5): 593-603, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26950238
3.
Sequential therapy for patients with primary refractory acute myeloid leukemia: a historical prospective analysis of the German and Israeli experience.
Haematologica
; 104(9): 1798-1803, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30733263
4.
Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive postremission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemia.
Haematologica
; 109(6): 1973-1976, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38385304
5.
Autoimmune basal ganglia encephalitis with hemolytic anemia.
Ann Hematol
; 101(8): 1857-1858, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35449425
6.
Similar outcome after allogeneic stem cell transplantation with a modified FLAMSA conditioning protocol substituting 4 Gy TBI with treosulfan in an elderly population with high-risk AML.
Ann Hematol
; 96(3): 479-487, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27909887
7.
FLAMSA reduced-intensity conditioning is equally effective in AML patients with primary induction failure as well as in first or second complete remission.
Eur J Haematol
; 96(5): 475-82, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26132980
8.
OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation.
Eur J Haematol
; 96(1): 27-35, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25703164
9.
CD4+ T cell counts reflect the immunosuppressive state of CD4 helper cells in patients after allogeneic stem cell transplantation.
Ann Hematol
; 94(1): 129-37, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25118994
10.
Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
Cochrane Database Syst Rev
; (4): CD010189, 2014 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24748537
11.
A post hoc analysis of the EPAZ trial: The role of geriatric variables in elderly soft tissue sarcoma patients on toxicity and outcome.
Eur J Cancer
; 181: 145-154, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36657323
12.
Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia.
Ann Hematol
; 91(1): 47-55, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21584670
13.
Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.
Cochrane Database Syst Rev
; (9): CD009159, 2012 Sep 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-22972135
14.
Targeted therapy of soft tissue sarcomas.
Onkologie
; 35 Suppl 1: 21-7, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22286584
15.
Preinfection laboratory parameters may predict COVID-19 severity in tumor patients.
Cancer Med
; 10(13): 4424-4436, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34121360
16.
Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas.
Blood Adv
; 5(13): 2707-2716, 2021 07 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34196677
17.
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia.
Blood Cancer J
; 11(10): 164, 2021 10 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34608129
18.
Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab.
Ann Hematol
; 89(10): 1029-33, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20422413
19.
Quality of life and added value of a tailored palliative care intervention in patients with soft tissue sarcoma undergoing treatment with trabectedin: a multicentre, cluster-randomised trial within the German Interdisciplinary Sarcoma Group (GISG).
BMJ Open
; 10(8): e035546, 2020 08 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32859662
20.
Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup Study.
J Clin Oncol
; 38(30): 3555-3564, 2020 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32840417